









Markets
/
Stocks
/
nasdaq-mdls
/

MDNA Life Sciences Units (Proposed)

MDLS

0.000

Close 12/19, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



MDNA Life Sciences Units (Proposed)

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of MDNA Life Sciences Units (Proposed) to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2023Q1

FY2022Q4

FY2022Q1

FY2021Q4

Operating cash flows (indirect method)

Cash flow from continuing operating activities

--172.21K

100.54%3.46K

---373.29K

---636.13K

Net income from continuing operations

---1.54M

-68.94%-1.37M

---1.70M

---812.49K

Operating gains losses

--88.40K

48.11%128.28K

--124.32K

--86.61K

Other non-cash items

--539.50K

-59.65%65.19K

--297.00K

--161.58K

Change in working capital

--1.29M

1741.72%1.18M

--838.74K

---71.84K

-Change in receivables

--364.21K

-1076.90%-359.13K

---34.90K

---30.52K

-Change in inventory

----

-100.00%0.00

----

--36.78K

-Change in prepaid expenses

--6.74K

210.89%94.18K

---48.70K

--30.29K

-Change in payables and accrued expense

--146.52K

374.62%495.34K

---299.11K

---180.37K

-Change in other current liabilities

--311.97K

224.75%336.79K

--784.24K

---269.97K

Cash from non-recurring investing activities

Cash from operating activities

--172.21K

100.54%3.46K

---373.29K

---636.13K

Investing cash flow

Net cash from continuing investing activities

--38.70K

-100.00%0.00

--0.00

--359.00

Capital expenditures

--38.70K

-100.00%0.00

--0.00

--359.00

Net cash flow from disposal of fixed assets

--38.70K

-100.00%0.00

--0.00

--359.00

Cash from non-current investing activities

Net cash flow from investing activities

---38.70K

100.00%0.00

--0.00

---359.00

Financing cash flow

Cash flow from continuous financing activities

--140.67K

-118.98%-200.42K

--300.00K

--1.06M

Net cash flow from debt Issuance/repayment

--140.67K

-85.26%203.18K

--300.00K

--1.38M

Net cash flow from other financing activities

----

-25.18%-403.60K

----

---322.43K

Net cash from non-recurrent financing activities

Net cash from financing activities

--140.67K

-118.98%-200.42K

--300.00K

--1.06M

Net cash flow

Beginning cash balance

--38.24K

-99.02%4.29K

--958.21K

--436.71K

Current period cash flow changes

--181.30K

-93.49%33.95K

--151.99K

--521.50K

Effect of exchange rate changes

---92.88K

126.59%230.91K

--225.28K

--101.91K

Ending cash balance

--219.54K

-96.01%38.24K

--1.11M

--958.21K

Free cash flow

--133.51K

100.54%3.46K

---373.29K

---636.49K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

